These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 95370)

  • 1. [Drug metabolism in liver diseases].
    Paumgartner G
    Z Gastroenterol Verh; 1979; 16():42-7. PubMed ID: 95370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in drug kinetics in liver diseases and their importance in rational pharmacotherapy].
    Danysz A
    Pol Tyg Lek; 1977 Dec; 32(52):2057-60. PubMed ID: 604977
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug metabolism in patients with liver disease.
    Secor JW; Schenker S
    Adv Intern Med; 1987; 32():379-405. PubMed ID: 3548257
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of various physiological and pathological conditions on the bioavailability of drugs].
    Danysz A; Wierzba K
    Pol Tyg Lek; 1979 Jan; 34(4):141-3. PubMed ID: 432125
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of disease on the metabolism and effects of drugs in man].
    Lavigne JG
    Union Med Can; 1980 Dec; 109(12):1718-22. PubMed ID: 7210314
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug metabolism in liver disease.
    Prescott LF; Forrest JA; Adjepon-Yamoah KK; Finlayson ND
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():62-5. PubMed ID: 783214
    [No Abstract]   [Full Text] [Related]  

  • 7. Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination.
    Hepner GW; Vesell ES; Lipton A; Harvey HA; Wilkinson GR; Schenker S
    J Lab Clin Med; 1977 Sep; 90(3):440-56. PubMed ID: 894100
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug metabolism in patients with liver disease (author's transl)].
    Richter E; Epping J; Fuchshofen-Röckel M; Heusler H; Zilly W
    Leber Magen Darm; 1980 Oct; 10(5):234-40. PubMed ID: 7464410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prescription of drugs in liver diseases].
    Held H
    Internist (Berl); 1980 Dec; 21(12):724-34. PubMed ID: 7009474
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of hepato-biliary diseases on drug metabolism (author's transl)].
    Pessayre D; Allemand H; Benhamou JP
    Nouv Presse Med; 1977 Oct; 6(35):3209-19. PubMed ID: 928049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: The influence of chronic liver disease on the elimination of d-propranolol, anti-pyrine, and indocyanine green.
    Branch RA; James JA; Read AE
    Gut; 1974 Oct; 15(10):837-8. PubMed ID: 4434964
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug metabolism in rats bearing a pituitary mammotropic tumor.
    Villeneuve JP; Gerber JG; Branch RA; Shand DG; Wilson JT
    J Pharmacol Exp Ther; 1979 Apr; 209(1):7-11. PubMed ID: 430380
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Drug metabolism in disease.
    Lancet; 1974 Apr; 1(7861):790-1. PubMed ID: 4132718
    [No Abstract]   [Full Text] [Related]  

  • 15. [Liver and metabolism of drugs].
    Darnis F
    Cah Med; 1974 Oct; 15(10):637-43. PubMed ID: 4455367
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of liver disease on drug pharmacokinetics].
    Su CY
    Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):238-42. PubMed ID: 6648457
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of drugs in reduced liver function].
    Spigset O
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2645-6. PubMed ID: 16215611
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug disposition in liver disease.
    Shand DG
    N Engl J Med; 1977 Jun; 296(26):1527-8. PubMed ID: 865536
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dose adaptation of drugs for liver patients using a simple risk classification].
    Zysset T; Bircher J
    Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.